Form 4: Inari Medical Director William Hoffman Executes Stock Sale Under 10b5-1 Plan

Director William Hoffman sold 20,000 shares of Inari Medical (NARI) common stock at an average price of $50.15, while also having shares withheld to cover tax obligations related to vesting restricted share units.

Summary

• William Hoffman, a director at Inari Medical, sold 20,000 shares of common stock on July 1, 2024, at a weighted average price of $50.15.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 14, 2023.
• Additionally, Inari Medical withheld 678 and 1,385 shares of common stock to cover Hoffman's tax obligations related to the vesting of restricted share units awarded in 2021 and 2022, respectively.
• Following these transactions, Hoffman directly owns 803,296 shares of Inari Medical common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company directors and officers, which is important for investors to monitor.

Stakeholder Impact

• The stock sale by a director could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates concerns about opportunistic trading.
• The withholding of shares for tax obligations has no direct impact on stakeholders.

Key Dates